[{"address1": "3060 Pegasus Park Drive", "address2": "Building 6", "city": "Dallas", "state": "TX", "zip": "75247", "country": "United States", "phone": "310 618 6994", "website": "https://www.fortebiorx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul A.  Wagner Ph.D.", "age": 55, "title": "CEO, President & Chairman", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1030848, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antony A. Riley CPA", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 652090, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barbara K. Finck M.D.", "age": 78, "title": "Chief Medical Clinician & Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 488057, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Roenfeldt", "title": "Chief Operating Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 29.67, "open": 29.49, "dayLow": 28.09, "dayHigh": 30.645, "regularMarketPreviousClose": 29.67, "regularMarketOpen": 29.49, "regularMarketDayLow": 28.09, "regularMarketDayHigh": 30.645, "payoutRatio": 0.0, "beta": 3.244, "forwardPE": -8.09816, "volume": 159989, "regularMarketVolume": 159989, "averageVolume": 190283, "averageVolume10days": 164640, "averageDailyVolume10Day": 164640, "bid": 29.8, "ask": 29.82, "bidSize": 1, "askSize": 1, "marketCap": 363782208, "fiftyTwoWeekLow": 4.9, "fiftyTwoWeekHigh": 35.62, "allTimeHigh": 6732.375, "allTimeLow": 4.11, "fiftyDayAverage": 28.1591, "twoHundredDayAverage": 16.134375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 270368192, "profitMargins": 0.0, "floatShares": 6635142, "sharesOutstanding": 12526935, "sharesShort": 688524, "sharesShortPriorMonth": 511832, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.055, "heldPercentInsiders": 0.03968, "heldPercentInstitutions": 1.00133, "shortRatio": 3.18, "shortPercentOfFloat": 0.0651, "impliedSharesOutstanding": 12526935, "bookValue": 4.717, "priceToBook": 6.1564555, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -51742000, "trailingEps": -0.08, "forwardEps": -3.586, "lastSplitFactor": "1:25", "lastSplitDate": 1724803200, "enterpriseToEbitda": -5.065, "52WeekChange": 2.0746114, "SandP52WeekChange": 0.14684999, "quoteType": "EQUITY", "currentPrice": 29.04, "targetHighPrice": 75.0, "targetLowPrice": 54.0, "targetMeanPrice": 63.75, "targetMedianPrice": 63.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 93414000, "totalCashPerShare": 7.457, "ebitda": -53382000, "totalDebt": 0, "quickRatio": 7.231, "currentRatio": 7.344, "returnOnAssets": -0.58066005, "returnOnEquity": -1.10722, "freeCashflow": -24480124, "operatingCashflow": -44425000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FBRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyDayAverageChange": 0.88090134, "fiftyDayAverageChangePercent": 0.03128301, "twoHundredDayAverageChange": 12.905626, "twoHundredDayAverageChangePercent": 0.7998839, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_594626683", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Forte Biosciences, Inc.", "longName": "Forte Biosciences, Inc.", "regularMarketChangePercent": -2.12335, "regularMarketPrice": 29.04, "corporateActions": [], "postMarketTime": 1771625376, "regularMarketTime": 1771621201, "postMarketChangePercent": 0.0, "postMarketPrice": 29.04, "postMarketChange": 0.0, "regularMarketChange": -0.629999, "regularMarketDayRange": "28.09 - 30.645", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 190283, "fiftyTwoWeekLowChange": 24.140001, "fiftyTwoWeekLowChangePercent": 4.926531, "fiftyTwoWeekRange": "4.9 - 35.62", "fiftyTwoWeekHighChange": -6.579998, "fiftyTwoWeekHighChangePercent": -0.18472762, "fiftyTwoWeekChangePercent": 207.46114, "dividendDate": 1592265600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.08, "epsForward": -3.586, "epsCurrentYear": -4.22, "priceEpsCurrentYear": -6.881517, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1492090200000, "displayName": "Forte Biosciences", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]